Vitamin E doesn't slow progression to Alzheimer's disease
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7497.923 (Published 21 April 2005) Cite this as: BMJ 2005;330:923- David Spurgeon
- Quebec
Vitamin E, a widely used early intervention for Alzheimer's disease, had no effect on 769 patients with mild cognitive impairment enrolled in a three year randomised placebo controlled doubleblind study published online on 13 April by the New England Journal of Medicine (www.nejm.org, doi:10.1056/NEJMoa050151). The study also showed that although donepezil (Aricept)showed no slowing of the rate of progression of the disease after three years compared with placebo, the drug was associated with a lower rate of progression during the first 12 months of treatment. Patients with an apolipoprotein E allele, which is a risk factor for Alzheimer's disease, showed a significant effect at one, two, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.